BioCentury
ARTICLE | Company News

Advancis sales and marketing update

June 13, 2005 7:00 AM UTC

AVNC launched its Keflex powder for oral suspension in the U.S. to treat respiratory tract infections, otitis media, skin and skin structure infections (SSSIs) and other bacterial infections. AVNC ac...